GL1X · GenesisL1 explorer

MolNFT v1 · #23404 · protein

X-ray structure of northeast structural genomics consortium target SOR45

1TZA · Apag protein: “X-ray structure of northeast structural genomics consortium target SOR45”. X-ray diffraction, 2 pockets (best druggability 0.63). MolNFT v1 #23404 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1TZA
Type
protein
Length
261 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Apag protein
UniProt
Q8EB92
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 1% helix, 63% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AApag proteinprotein1322% helix, 63% strandQ8EB92
BApag proteinprotein1290% helix, 63% strandQ8EB92

Ligands and binding sites

  • CAC · Cacodylate ion · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12690.630.8133empty
2810.420.7916CAC

Interfaces

1 interface between chains.

  • A–B · 686 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (engineered).

Compared structures

  • 1TZA · X-ray structure of Northeast Structural Genomics Consortium target SoR45 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8EB92 · AlphaFold monomer V2.0 prediction for protein apag (Q8EB92) · a predicted model of the same protein · chain B against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.